Stocksigma LogoStocksigma Logo

Shukra Pharmaceuticals Allots Equity Shares on Warrant Conversion

Shukra Pharmaceuticals approved the allotment of 17,35,000 equity shares of Re.1/- each on 6th Oct'26 upon converting warrants held by promoter entities

Shukra Pharmaceuticals Allots Equity Shares on Warrant Conversion

Shukra Pharmaceuticals Ltd 路 Others (Uncategorized) 路 07 Oct 2026, 12:12 am

Shukra Pharmaceuticals Allots Equity Shares on Warrant Conversion Shukra Pharmaceuticals approved the allotment of 17,35,000 equity shares of Re.1/- each on 6th Oct'26 upon converting warrants held by promoter entities Ms. Anar Jayesh Patel and Anar Projects Private Limited. The allotment follows receipt of the 75% balance exercise price at Rs.26.67 per warrant, aggregating Rs.4.63 cr. Consequently, paid-up equity capital increased to Rs.44.25 cr (44,25,22,440 shares), with the combined promoter entities' holding rising from 19.70% to 20.01%. All 46,43,000 warrants allotted on 28th Jan'26 are fully converted, leaving zero outstanding warrants.

Original exchange filing (PDF)

More announcements from Shukra Pharmaceuticals Ltd

All Shukra Pharmaceuticals Ltd announcements